Basic Information | Post buying leads | Suppliers |
Name |
Moveltipril calcium |
EINECS | N/A |
CAS No. | 85921-53-5 | Density | 1.248g/cm3 |
PSA | 236.16000 | LogP | 4.58920 |
Solubility | N/A | Melting Point |
~190° |
Formula | C19H30 N2 O5 S . 1/2 Ca | Boiling Point | 658.9°Cat760mmHg |
Molecular Weight | 835.10 | Flash Point | 352.3°C |
Transport Information | N/A | Appearance | N/A |
Safety | Risk Codes | N/A | |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
L-Proline,1-[3-[[2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-,calcium salt (2:1), [R-(R*,S*)]-; Altiopril calcium; L-Proline,1-[(2S)-3-[[(2R)-2-[(cyclohexylcarbonyl)amino]-1-oxopropyl]thio]-2-methyl-1-oxopropyl]-,calcium salt (2:1); Lowpres; MC 838; Moveltipril calcium |
Molecular Structure:
Molecular Formula: 2(C19H29N2O5S).Ca
Molecular Weight: 835.10
Product Name: Moveltipril calcium
Synonyms of Moveltipril calcium (CAS NO.85921-53-5): MC 838 ; Moveltipril calcium salt ; Altiopril calcium ; Calcium (-)-N-(((S)-3-(N-cyclohexylcarbonyl-D-alanyl)thio)-2-methylpropionyl)-L-prolinate ; Lowpres ; MC-838 ; L-Proline, 1-(3-((2-((cyclohexylcarbonyl)amino)-1-oxopropyl)thio)-2-methyl-1-oxopropyl)-, calcium salt (2:1), (R-(R*,S*))-
CAS NO: 85921-53-5
Product Categories: Drug / Therapeutic Agent ; Reproductive Effect
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | > 6gm/kg (6000mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
mouse | LD50 | intraperitoneal | 2100mg/kg (2100mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
mouse | LD50 | subcutaneous | 3gm/kg (3000mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
rat | LD50 | intraperitoneal | 1300mg/kg (1300mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. | |
rat | LD50 | subcutaneous | 3400mg/kg (3400mg/kg) | Tohoku Journal of Experimental Medicine. Vol. 152, Pg. 363, 1987. |